Daiwa Securities Group Inc. - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 127 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$0
-100.0%
1760.0%0.00%
Q1 2024$10.0%1760.0%0.00%
Q4 2023$10.0%1760.0%0.00%
Q3 2023$10.0%1760.0%0.00%
Q2 2023$10.0%1760.0%0.00%
Q1 2023$10.0%1760.0%0.00%
Q4 2022$1
-100.0%
1760.0%0.00%
Q3 2022$2,000
+100.0%
1760.0%0.00%
Q2 2022$1,000
-50.0%
1760.0%0.00%
Q1 2022$2,000
-33.3%
1760.0%0.00%
Q4 2021$3,0001760.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 544,196$5,741,00019.52%
Elmwood Wealth Management, Inc. 2,364,240$24,943,00012.45%
72 Investment Holdings, LLC 474,067$5,001,0003.96%
PFM Health Sciences, LP 6,000,000$63,300,0002.29%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 257,892$2,716,0000.87%
Avidity Partners Management LP 3,172,600$33,471,0000.68%
Rokos Capital Management LLP 1,907,509$20,811,0000.62%
Green Alpha Advisors, LLC 69,376$732,0000.62%
Nelson Capital Management, LLC 85,020$897,0000.26%
Tekla Capital Management LLC 567,147$5,983,0000.24%
View complete list of CARIBOU BIOSCIENCES INC shareholders